EFFECTS OF 12-O-TETRADECANOYL-PHORBOL-13-ACETATE ON MYOFIBRIL INTEGRITY AND CA2+ CONTENT IN DEVELOPING MYOTUBES
EFFECTS OF 12-O-TETRADECANOYL-PHORBOL-13-ACETATE ON MYOFIBRIL INTEGRITY AND CA2+ CONTENT IN DEVELOPING MYOTUBES
复制标题
DOI:
10.1016/0012-1606(82)90334-7
复制
发表时间:
1982-01-01
影响因子:
2.7
通讯作者:
HOLTZER, H
中科院分区:
文献类型:
--
作者:
CROOP, J;DUBYAK, G;HOLTZER, H
The cocarcinogen 12-O-tetradecanoyl-phorbol-13-acetate (TPA) has a prompt and selective effect on [chick embryo] striated myofibrils in well-formed, multinucleated myotubes. The myofibrillar apparatus is totally disrupted and largely degraded after 3 days in TPA. Fluorescent-tagged antibodies to muscle-specific light meromyosin and EM document this catabolic effect of TPA. This selective degradation of fully assembled striated myofibrils is readily reversible. This reassembly of myofibrils requires de novo protein synthesis. The TPA-treated myotubes are unusually rich in autophagosomes, organelles rarely observed in normal myotubes. TPA has no discernable effect on the morphology of the subsarcolemmal microfilaments, mitochondria, microtubules or sarcoplasmic reticulum (SR). The programmed disappearance of the fibroblast-type, intermediate 10-nm filaments (FIF) that occurs as normal myotubes mature is not altered by TPA. The TPA-treated myotubes depleted of myofibrils are filled with an extensive meshwork of the muscle-type intermediate 10-nm filaments (MIF). The drug has no obvious effect on the constitutive contractile proteins comprising the submembranous microfilaments, or the FIF in presumptive myoblasts or fibroblasts, nor does it affect the motility associated with these replicating cells. The striking increase in total Ca content which occurs as normal myotubes mature is absent in myotubes treated with TPA.